A. Menarini Diagnostics Srl-医療機器分野:企業M&A・提携分析

◆英語タイトル:A. Menarini Diagnostics Srl - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011430
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
A. Menarini Diagnostics Srl (Menarini Diagnostics), a subsidiary of A Menarini Industrie Farmaceutiche Riunite Srl is a medical device company that offers in-vitro diagnostic products. The company provides pharmaceutical testing products including home glucose testing products, oral anticoagulant therapy monitoring PT and INR testing products, haemoglobin analyzers, urinalysis products, professional monitoring devices, fobt products, and biochemistry products. Its other products include diagnostics products, urine sediment testing devices, point of care testing devices, autoimmunity, cell pathology, hematology testing, and animal health products. Menarini Diagnostics also offers technology solutions to its customers. Its products are used in the fields of diabetes, immunology, haematology, point-of-care treatment, and histology. The company has its presence in France, Italy, Germany, the UK, and other countries. Menarini Diagnostics is headquartered in Firenze, Italy.

A. Menarini Diagnostics Srl – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
A. Menarini Diagnostics Srl, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
A. Menarini Diagnostics Srl, Medical Equipment Deals By Type, 2011 to YTD 2017 6
A. Menarini Diagnostics Srl, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
A. Menarini Diagnostics Srl, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
A. Menarini Diagnostics Srl, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
A. Menarini Diagnostics Srl, Medical Equipment, Deal Details 10
Partnerships 10
Mendor Enters Into Distribution Agreement With Menarini For GlucoMen Ready 10
Probe Scientific Enters Into Co-Development Agreement With A. Menarini Diagnostics 11
Mendor Enters Into Distribution Agreement With A.Menarini For Glucose Meter 12
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics 13
Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 14
A. Menarini Diagnostics Srl – Key Competitors 15
A. Menarini Diagnostics Srl – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
A. Menarini Diagnostics Srl, Medical Equipment, Key Facts 2
A. Menarini Diagnostics Srl, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
A. Menarini Diagnostics Srl, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
A. Menarini Diagnostics Srl, Medical Equipment Deals By Type, 2011 to YTD 2017 6
A. Menarini Diagnostics Srl, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
A. Menarini Diagnostics Srl, Deals By Market, 2011 to YTD 2017 8
A. Menarini Diagnostics Srl, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Mendor Enters Into Distribution Agreement With Menarini For GlucoMen Ready 10
Probe Scientific Enters Into Co-Development Agreement With A. Menarini Diagnostics 11
Mendor Enters Into Distribution Agreement With A.Menarini For Glucose Meter 12
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics 13
Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 14
A. Menarini Diagnostics Srl, Key Competitors 15

★海外企業調査レポート[A. Menarini Diagnostics Srl-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • NeoTract Inc:医療機器:M&Aディール及び事業提携情報
    Summary NeoTract Inc (NeoTract) is a medical device company that designs and develops minimally invasive devices for use in the field of urology. The company’s urolift system is designed to treat lower urinary tract symptoms caused by benign prostatic hyperplasia. It partners with its customers to i …
  • PMA Companies, Inc.:企業の戦略・SWOT・財務情報
    PMA Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary PMA Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Carmell Therapeutics Corp:製品パイプライン分析
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio encompasses adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for tot …
  • Inretail Peru Corp. (INRETC1):企業の財務・戦略的SWOT分析
    Inretail Peru Corp. (INRETC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • GL Pharm Tech Corp (204840):製薬・医療:M&Aディール及び事業提携情報
    Summary GL Pharm Tech Corp (GL Pharm) is a pharmaceutical company. The company offers drug formulations and delivery technologies for generic marketed drug. It provides incrementally modified drugs, generic drugs, and G-SOREN Tab. GL Pharm provides generic drugs such as olmesartan, atorvastatin, ler …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務分析
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Qantas Airways Ltd (QAN):企業の財務・戦略的SWOT分析
    Qantas Airways Ltd (QAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Northwest Territories Power Corporation:発電所・企業SWOT分析
    Northwest Territories Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Mitsui & Co., Ltd.:企業のM&A・事業提携・投資動向
    Mitsui & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsui & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • Hinduja Global Solutions Ltd (HGS):企業の財務・戦略的SWOT分析
    Hinduja Global Solutions Ltd (HGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Seacoast Banking Corporation of Florida:企業の戦略・SWOT・財務情報
    Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report Summary Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Consolidated Edison Company of New York Inc:企業の発電所・SWOT分析2018
    Consolidated Edison Company of New York Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Glory Ltd:企業の戦略・SWOT・財務情報
    Glory Ltd - Strategy, SWOT and Corporate Finance Report Summary Glory Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fisher & Paykel Appliances Holdings Limited:企業の戦略的SWOT分析
    Fisher & Paykel Appliances Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Chesterton Global Ltd:企業の戦略的SWOT分析
    Chesterton Global Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • G. Pohl-Boskamp GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary G. Pohl-Boskamp GmbH & Co KG (Pohl-Boskamp) is a developer of medicines and medical devices. The company offers products which include GeloMyrtol forte, GeloRevoice, GeloSitin Nasenpflege, GeloSitin Nasal Care, GeloBronchial-Saft, GeloDurat-Salbe, GeloDuratInhalator N, Laxopol, Nitrolingual …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆